Delivery Order SPE2DB22D1103-SPE2DB25FH2W9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with a ceiling value of $2,015.02. This contract is a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,608.29 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,029.32 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count) on August 21, 2025, with a completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded delivery order has a ceiling value of $3,822.24 and is structured as a firm fixed price contract with an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Telmisartan 80 mg tablets (30-count units) valued at $1,276.09. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025. This delivery order is issued under...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2W9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with a contract ceiling value of $1,677.93. This firm fixed-price delivery order, awarded on September 23, 2025, represents a non-competitive, non-set-aside contract with a completion date of September 24, 2025. Performance is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child contract action, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion pharmaceutical supply vehicle designated SPE2DX that runs through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical supply chain, providing a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contracting history demonstrates capability in delivering diverse pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs and medical devices. This delivery order for Telmisartan, an antihypertensive medication, exemplifies the routine pharmaceutical procurement activities executed under AmerisourceBergen's prime vendor agreements with the Defense Logistics Agency to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/23/25 |